The Sunnybrook Health Sciences Centre will soon provide patients with medical cannabis products on site via its Odette Cancer Centre Pharmacy. This is one of the first time a hospitals to offer cannabis as a treatment option.
According to information procured exclusively ahead of an official announcement, the initiative, led in partnership with publicly traded cannabinoid biotech company Avicanna Inc., will make the company’s RHO Phyto product line available to Sunnybrook patients under a doctor’s prescription. The deal also includes patient and physician education components.
“Patients have questions about, and want access to, plant-based cannabinoids, and that requires healthcare professionals to become knowledgeable about the use of cannabinoids for medical purposes,” said Carlo DeAngelis, pharmacist and researcher at Sunnybrook’s Odette Cancer Centre.
– Read the entire article at Forbes.